as the phosphate. Names Brand names include Chloroquine FNA, Resochin, Dawaquin, and Lariago. Other animals Chloroquine, in various chemical forms, is used to treat and control surface growth of anemones and algae, and many protozoan infections in aquariums, e.g. the fish parasite Amyloodinium ocellatum. It is also used in poultry malaria. Research Chloroquine was proposed as a treatment for SARS, with in vitro tests inhibiting the severe acute respiratory syndrome coronavirus (SARS-CoV). In October 2004, a published report stated that chloroquine acts as an effective inhibitor of the replication of SARS-CoV in vitro. In August 2005, a peer-reviewed study confirmed and expanded upon the results. Chloroquine was being considered in 2003, in pre-clinical models as a potential agent against chikungunya fever. COVID-19 Other The radiosensitizing and chemosensitizing properties of chloroquine are being evaluated for anticancer strategies in humans. In biomedicinal science, chloroquine is used for in vitro'' experiments to inhibit lysosomal degradation of protein products. Chloroquine and its modified forms have also been evaluated as treatment options for inflammatory conditions like rheumatoid arthritis and inflammatory bowel disease. References External links 1934 introductions Antimalarial agents Chloroarenes CYP2D6 inhibitors AstraZeneca brands Diethylamino compounds HERG blocker Quinolines World Health Organization essential medicines Wikipedia medicine articles ready to translate German inventions of the Nazi period Disease-modifying antirheumatic drugs